Skip to results
Modify your search
NARROW
1-5 of 5
Authors: Timothy A Yap
Sort by
Journal Article
Barriers to publishing early phase clinical trials: the oncologists’ perspective
Merel J J Lucassen and others
The Oncologist, Volume 30, Issue 4, April 2025, oyaf042, https://doi.org/10.1093/oncolo/oyaf042
Published: 24 April 2025
Journal Article
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis
Funda Meric-Bernstam and others
The Oncologist, Volume 30, Issue 3, March 2025, oyaf031, https://doi.org/10.1093/oncolo/oyaf031
Published: 26 March 2025
Journal Article
First-In-Human , First-In-Class , Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
Khanh T. Do and others
The Oncologist, Volume 26, Issue 11, November 2021, Pages 925–e1918, https://doi.org/10.1002/onco.13911
Published: 22 September 2021
Journal Article
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials
Ryan W. Huey and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 588–596, https://doi.org/10.1002/onco.13767
Published: 21 April 2021
Journal Article
Development of Molecularly Driven Targeted Combination Strategies
Timothy A. Yap and Jordi Rodon
The Oncologist, Volume 22, Issue 12, December 2017, Pages 1421–1423, https://doi.org/10.1634/theoncologist.2017-0402
Published: 04 December 2017
Advertisement
Advertisement